Yevgeniy Samyshkin - Health Economics and Outcomes Research, IMS Health

基本信息

浏览量：40

职业迁徙

个人简介

strategic use of health economics, early value assessments, evidence generation strategies and planning, cross-disciplinary collaborations, innovative methods

研究兴趣

论文共 65 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-world Treatment Patterns and Outcomes in US Patients (pts) with Advanced Non-Small Cell Lung Cancer (NSCLC) after Platinum-Based Chemotherapy (PBC) and Anti–pd-(L)1 Treatment

Vamsidhar Velcheti, Julia Moore, Huifen Wang, Xinmei Zhu,Yevgeniy Samyshkin, Thomas Ward, Alena Christensen,Caitlyn Solem

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective

T. Liu,M. Purser, C. Gong, D. Elsea, N. Niehoff,E. Dlotko,K. Migliaccio-Walle,Y. Samyshkin

Value in Healthno. 6 (2024): S112-S112

引用0浏览0引用

#4140 DAPRODUSTAT VERSUS RECOMBINANT HUMAN ERYTHROPOIETIN FOR TREATING ANAEMIA OF CHRONIC KIDNEY DISEASE: COST EFFECTIVENESS MODEL METHODOLOGY AND FINDINGS

Alfred Sackeyfio,Yevgeniy Samyshkin, Justin Riemer,Michelle Blake, Simbarashe Mhishi, Marie Prett, Laura Elliot,Rodrigo Refoios Camejo

Nephrology Dialysis Transplantationno. Supplement_1 (2023)

引用0浏览0引用

An Epidemiology Model for Estimating the Numbers of US Patients with Multiple Myeloma by Line of Therapy and Treatment Exposure

Andreas Nikolaou,Cosmina Hogea,Yevgeniy Samyshkin,Eric M. Maiese,Leah Sansbury,Mustafa Oguz,Javier Cid-Ruzafa,Ritika Kapoor,Feng Wang

Value in health（2022）

引用0浏览0WOS引用

EPH134 Economic and Utility Evidence for Metastatic Synovial Sarcoma and Myxoid Round Cell Liposarcoma: A Systematic Literature Review

M. Purser,Y. Samyshkin, S. Dodman, E. Zhang, D. Teloian

Value in health（2022）

引用0浏览0引用

Feasibility study of an indirect treatment comparison and population-adjusted indirect treatment comparison of niraparib, olaparib, and bevacizumab as maintenance therapies in women with newly diagnosed advanced ovarian cancer

K. Baumann,D. Lorusso,H. Guy, J. Hamilton,Y. Samyshkin,K. Travers,C. Hawkes,R. Coleman

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

Budget Impact of Belantamab Mafodotin (belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States

Anshul Shah,Jonathan C. Tosh,Apoorva Ambavane,Andreas Nikolaou,Cosmina Hogea,Yevgeniy Samyshkin,Boris Gorsh,Eric M. Maiese,Feng Wang

ClinicoEconomics and outcomes research（2021）

引用0浏览0WOS引用

Belantamab Mafodotin for the Treatment of Relapsed/refractory Multiple Myeloma in Heavily Pretreated Patients: a US Cost-Effectiveness Analysis

Andreas Nikolaou,Apoorva Ambavane,Anshul Shah, Wenkang Ma,Jonathan Tosh,Venediktos Kapetanakis,Jenny Willson, Wenfang Feng,Cosmina Hogea,Boris Gorsh, Ben Gutierrez,Sandhya Sapra, Attaya Suvannasankha,Yevgeniy Samyshkin

Expert review of hematology（2021）

引用0浏览0引用

Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis

Andreas Nikolaou,Apoorva Ambavane,Anshul Shah, Wenkang Ma,Jon Tosh,Venediktos Kapetanakis,Jenny Willson,Feng Wang,Cosmina Hogea,Boris Gorsh, Ben Gutierrez,Sandhya Sapra,Attaya Suvannasankha,Yevgeniy Samyshkin

EXPERT REVIEW OF HEMATOLOGY（2021）

引用3浏览0WOS引用

Ceor_a_310619 789..800

Anshul Shah,Jonathan C Tosh,Apoorva Ambavane,Andreas Nikolaou,Cosmina Hogea,Yevgeniy Samyshkin,Boris Gorsh,Eric M Maiese, Feng Wang

semanticscholar（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn